BOSTON DR LIM

BIOTECH (109) MAIA Biotechnology: THIO – Telomere-Targeting Agent

March 4, 2024March 4, 2024

BIOTECH (108) Stapled Peptides: From Aileron to Fog Pharma

March 4, 2024March 4, 2024

부러우면 지는거다 (29) 최성락 경영학 박사

March 4, 2024March 4, 2024

BIOTECH (107) Sana Biotechnology의 Fusogen Platform 보류에 대한 소고

March 3, 2024March 4, 2024

BIOTECH (106) Point Biopharma: Precision Radioligand Therapy (RLT)

March 3, 2024March 3, 2024

BIOTECH (105) Entos Pharmaceuticals: Fusogenix Proteolipid Vehicle (PLV) Platform

March 3, 2024March 3, 2024

BIOTECH (104) Novartis: Pluvicto (177Lu-PSMA-617) – the First Precision Radiopharmaceuticals

March 2, 2024March 2, 2024

BIOTECH (103) Prime Medicine: Prime Editing

March 2, 2024March 2, 2024

BIOTECH (102) Elicio Therapeutics: Albumin-Hitchhiking Vaccine Amphiphile (AMP) Platform

March 1, 2024March 1, 2024

BIOTECH (101) Krystal Biotech: Redosable HSV-1 vector gene therapy – Vijuvek (beremagene geperpavec)

March 1, 2024March 1, 2024